Article info
Colon
Original research
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition
- Correspondence to Dr Lionel Le Bourhis, INSERM U1160, Institut de Recherche Saint-Louis, Saint Louis Hospital, Université de Paris, Paris, France; lionel.le-bourhis{at}inserm.fr
Citation
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition
Publication history
- Received November 12, 2021
- Accepted June 29, 2022
- First published July 8, 2022.
Online issue publication
March 07, 2023
Article Versions
- Previous version (8 July 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.